Oslo, Norway, 6 November 2013 - Algeta ASA (ALGETA.OL), a company focused on the development of novel targeted cancer therapeutics, announces its financial calendar for 2014:
4th Quarter Results 2013: 28 February 2014
1st Quarter Results 2014: 22 May 2014
2nd Quarter Results 2014: 21 August 2014
3rd Quarter Results 2014: 20 November 2014
Annual General Meeting: 29 April 2014
All dates are tentative and could be subject to change.
For further information, please contact:
|Mike Booth||+1 646 410 1884|
|Communications & Corporate Affairsfirstname.lastname@example.org|
|Mark Swallow||+44 207 638 9571|
|Citigate Dewe Rogersonemail@example.com|
|Knut Ekern||+47 22 04 82 00|
|Gambit Hill & Knowltonfirstname.lastname@example.org|
|Kari Watson||+1 781 235 3060|
|MacDougall Biomedical Communicationsemail@example.com|
|Tricia Truehart||+1 646 378 2953|
|The Trout Groupfirstname.lastname@example.org|
Algeta is a company focused on developing, manufacturing and marketing novel targeted therapies for patients with cancer. The Company is headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in Cambridge, MA performing commercial marketing operations in the US. Algeta is listed on the Oslo Stock Exchange (ALGETA.OL). For more information please visit www.algeta.com.
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. Press release
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: Algeta ASA via Thomson Reuters ONE